BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
Bausch Health reported second quarter 2026 revenue of $2.85 billion, a 13% increase year-over-year, with GAAP EPS of $0.68 and Adjusted EPS of $1.26, up 40% compared to the prior year. The company generated $671 million in cash from operating activities and reported cash and cash equivalents of $1.825 billion, significantly strengthening its balance sheet and reducing net debt.
Key figures
- Eps
- 0.68
- Revenue
- 2852000000
- Guidance
- FY26 Revenue $10.790B - $11.040B, Adj EBITDA $4.050B - $4.175B, Adj Cash Flow $1.400B - $1.475B
- Revenue Yoy
- 13%
- Adj eps
- 1.26
- Adj ebitda
- 1075000000
- Cash equivalents
- 1825000000
- Cash from operations
- 671000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.